Latitude Pharmaceuticals - drug formulation services

Medicinal chemistry, Lead optimization, In vitro drug screening

News/Press Releases on Latitude and its Formulations
April 03, 2012	LATITUDE Pharmaceuticals, Inc. Develops a Stable Liquid Glucagon Formulation
April 14, 2010	LATITUDE Pharmaceuticals Initiates Four Additional Collaboration Studies For Its PG yDepot
Sept. 15, 2009	Nano-E Antibacterial Emulsion Poster 49th ICAAC Annual Meeting
July 16, 2009	Latitude Signs Two More Collaboration Studies for PG Depot.
May 12, 2009	Nanoemulsions are a Superior Approach to Formulating Insoluble IV Drugs
May 07, 2009	ADVENTRX Announces Results form ANX-514 Bioequivalence Trial.
July 02, 2008	PainReform Licenses A Novel Sustained Release Formulation of Ropivacaine from Encore Therapeutics, Inc.
May 16, 2008	ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study.
May 10, 2008	Novalar Receives FDA Approval For OraVerse.